Filing Details
- Accession Number:
- 0001593968-21-002391
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 17:59:37
- Reporting Period:
- 2021-11-11
- Accepted Time:
- 2021-11-15 17:59:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668673 | Petiq Inc. | PETQ | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1781014 | A Michael Smith | 923 S Bridge Way Pl Eagle ID 83616-6885 | Evp - Products | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2021-11-11 | 4,000 | $22.62 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person's purchase of PETIQ common stock reported herein was matchable under Section 16b of the Securities Exchange Act of 1934, to the extent of 4,000 shares, with the reporting person's sale of 2,664 and 13,470 shares of PETIQ common stock at a price of $39.80 per share on June 10, 2021 and $39.53 per share on June 11, 2021, respectively. The reporting person has agreed to pay to PETIQ, upon settlement of the sale, $63,359.28 representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $22.70. The reporting person undertakes to provide to PetIQ, Inc., any security holder of PetIQ, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
